Sort
50,496 grants matching “lung cancer”
Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors
$510,311Rebecca Maureen Howell · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
$510,309Stephen S Hecht · University Of Minnesota · R37 · FY2009 · CA
Selective Inhibitors of T Cell Activation Target Exportin-1 at Cys528 to Suppress Pathological T Cell Activation
$510,221Drew James Adams · Case Western Reserve University · R01 · FY2023 · AI
Project 2 Human Tumor Analysis
$510,200Sylvia Katina Plevritis · Stanford University · U54 · FY2025 · CA
Addressing Fugitive Chemical Health Risks through Community-Based Actions
$510,194Ramya Chari · Rand Corporation · R01 · FY2017 · ES
Understanding the impact of chemotherapy on breast cancer metastasis and immune function in the liver
$510,175Sandra S McAllister · Brigham And Women'S Hospital · R01 · FY2023 · CA
An Intraoperative Guidance Platform for Radio Frequency Ablation
$510,164Andrea Borsic · Ne Scientific, Llc · R44 · FY2019 · CA
Mechanisms associated with organotropic metastasis
$510,140Raghu Kalluri · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
$510,090Stephen S Hecht · University Of Minnesota · R01 · FY2020 · CA
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
$510,090Stephen S Hecht · University Of Minnesota · R01 · FY2021 · CA
Molecular Signatures of Lung Cancer
$510,045David P Carbone · Ohio State University · U01 · FY2010 · CA
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease
$510,000Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2019 · HL
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease
$510,000Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2020 · HL
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease
$510,000Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2022 · HL
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease
$510,000Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2021 · HL
Preclinical Electron Paramagnetic Resonance Tumor Imager
$509,959Gareth R Eaton · University Of Denver (Colorado Seminary) · R01 · FY2023 · CA
Tumor gene expression in vitro and in vivo
$509,880Douglas R. Lowy · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Maladaptive epigenetic control of MUC5B transcription in pulmonary fibrosis
$509,866Anthony N Gerber · University Of Colorado Denver · P01 · FY2023 · HL
PROSPECTIVE STUDY OF DIET AND CANCER IN MEN (HEALTH PROFESSIONALS FOLLOWUP)
$509,810Harvard University (Medical School) · P01 · FY2000 · CA
Outcomes of Triaged Family Care in Advanced Cancer
$509,674Laurel L. Northouse · University Of Michigan At Ann Arbor · R01 · FY2007 · CA
Compounded Neuronal Damage in Comorbid Cigarette Smoking and Addiction
$509,603Karmen K Yoder · Indiana University Indianapolis · R01 · FY2022 · AA
Personalized Motion Management for truly 4D Lung Stereotactic Body Radiotherapy
$509,590Amit Sawant · Ut Southwestern Medical Center · R01 · FY2014 · CA
Lung Screening: Efficacy versus Effectiveness
$509,518Ilana F Gareen · Brown University · R01 · FY2021 · CA
Targeting cancer stem cells in JAK2V617F induced neoplasm
$509,492Shaoguang Li · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · CA
Improving Risk Factors for Diabetes Complications in Primary Care
$509,490Michael L Parchman · University Of Texas Hlth Science Center · R18 · FY2010 · DK